Aesthetik Engineers Peer Comparison

NSE: AESTHETIK

₹71.75

₹0.00 (0.00%)

As on 27-Aug-2026 10:49IST

Market cap

₹124 Cr

Revenue (TTM)

₹66 Cr

P/E Ratio

17.3

P/B Ratio

2.8

Div. Yield

0 %

Edit

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Market cap (₹ Cr)	124	18,021	7,077	4,793	2,652
Revenue (₹ Cr)	66	9,934	4,031	1,489	374
Net Profit (₹ Cr)	5.65	284.85	193.86	189.18	87.91
Net Margin (%)	8.42	2.85	4.74	12.33	22.95
RoE (%)	19.08	5.70	6.34	23.67	29.87
Price to Earnings	17.34	64.91	32.99	25.33	30.77
Price-To-Book	2.79	3.73	2.15	4.19	8.04

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Operating Revenue	66.24	10,545.09	3,439.20	1,273.69	284.23
Total Income	67.08	10,697.24	3,570.12	1,305.43	294.68
Total Expenditure	57.53	9,246.58	3,194.22	1,213.81	186.00
EBITDA	8.71	1,298.51	244.98	59.88	98.23
Depreciation	1.12	373.39	182.61	96.24	5.31
EBIT	7.59	925.12	62.37	-36.36	92.92
Interest	0.91	217.48	120.55	30.38	4.00
Other Income	0.85	152.15	130.92	31.74	10.45
Exceptional Items	--	--	30.59	--	--
Profit before Tax	7.53	860.18	103.33	-35.00	100.79
Provision for Tax	1.88	216.16	14.41	--	24.35
Profit after Tax	5.65	644.02	88.92	-35.00	76.44

Liabilities (₹ Cr)

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Shareholder's Funds	44.46	4,821.09	3,016.66	520.57	234.10
Minority Interest	--	99.57	7.49	--	0.39
Non-Current Liabilities	0.98	2,093.80	894.98	210.80	13.63
Current Liabilities	17.00	3,252.86	1,480.48	319.38	23.66
Total Liabilities	62.64	10,267.32	5,548.53	1,050.75	273.84

Assets (₹ Cr)

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Non-Current Assets	23.54	4,798.73	3,940.93	513.27	38.39
Current Assets	38.78	5,468.59	1,400.46	537.48	233.40
Total Assets	62.64	10,267.32	5,548.53	1,050.75	273.84
Total Debt*	9.60	2,468.62	1,216.49	0.00	2.68
Net Current Assets	21.78	2,215.73	-80.02	218.10	209.74
Contingent Liabilities	--	57.50	57.38	5.72	--

Cashflow (₹ Cr)

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Cash From Operating Activities	2.61	687.98	247.39	76.22	-30.65
Cash Flow from Investing Activities	-20.99	57.32	-23.88	-2.11	36.04
Cash from Financing Activities	19.97	-663.14	-226.32	-70.62	-1.88
Net Cash Inflow / Outflow	1.59	82.16	-2.81	3.49	3.52

Ratios

Profitability Ratios

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
ROCE (%)	21.83	15.04	5.31	-0.86	53.39
ROE (%)	19.08	13.83	3.00	-7.13	39.22
ROA (%)	12.15	6.52	1.66	-3.54	34.31
EBIT Margin (%)	14.42	13.76	10.93	7.19	38.24
Net Margin (%)	8.42	6.02	2.49	-2.68	25.94
Cash Profit Margin (%)	10.21	9.65	7.15	4.81	28.76

Growth Ratios

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Revenue Growth (%)	9.08	8.95	15.32	29.13	28.20
EBIT Growth (%)	22.36	-4.23	-9.99	36.64	21.49
Net Profit Growth (%)	12.29	-4.27	-54.29	-132.54	21.51
EPS Growth (%)	-17.13	-4.91	-51.24	-128.55	6.49
Book Value Growth (%)	198.73	6.55	3.08	-5.02	50.32

Valuation Ratios

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Price / Earnings	22.93	20.27	86.86	0.00	0.00
Price / Book Value	2.92	2.70	2.58	0.00	0.00
Dividend Yield (%)	0.00	1.26	0.00	--	--
EV/EBITDA	14.25	10.42	23.76	0.11	-0.01
Market Cap (₹ Cr)	129.50	12,952.53	7,760.55	0.00	0.00

Solvency Ratios

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Debt to Equity	0.22	0.51	0.40	0.00	0.01
Short term debt to equity ratio	0.19	0.30	0.04	--	0.01
Current Ratio	2.28	1.68	0.95	1.68	9.86
Quick Ratio	1.73	1.01	0.71	1.17	5.80
Interest Coverage	9.32	4.96	1.86	-0.15	26.17

Operating Efficiency Ratios

	Aesthetik Engineers	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Debtors to sales (%)	28.45	15.60	10.05	0.46	33.72
Asset Turnover	1.42	1.07	0.71	1.29	1.28
Receivable days	65.63	50.18	34.08	4.86	90.02
Inventory Days	56.35	73.64	33.12	42.17	84.61
Payable days	41.78	69.75	63.51	95.95	9.53
Cash Conversion Cycle	80.20	54.08	3.69	-48.91	165.10